The U.S. Life Science Tools Market is projected to grow from USD 68.50 Billion in 2025 to USD 189.48 Billion by 2035, while ...

Discover how connecting make and test workflows can accelerate drug discovery by improving decision-making across the DMTA ...

Researchers detected Usutu virus RNA in nine of 818 wild carnivores sampled across the Netherlands, while no animals tested ...

This article explores how biobanks, proteomics, and AI are enabling population-scale insights, earlier disease detection, and ...

A six-year-old boy from Sussex has become one of only about 75 people worldwide to be diagnosed with an ultra-rare genetic ...

The pharmacogenomic testing service market is witnessing strong growth, driven by the increasing adoption of personalized medicine and the growing recognition of genetic factors in drug response.

A research team led by Minyoung Lee and Sunggyu Park of The Korea Institute of Materials Science (KIMS) Bio & Health ...

The U.S. Aptamers Market is projected to grow from USD 1.49 Billion in 2025 to USD 11.90 Billion by 2035, while Europe is ...

DelveInsight's Pharmacogenomic Testing Service Market Insights report provides the current and forecast market analysis, individual leading pharmacogenomic testing service companies' market shares, ...

Asia-Pacific emerges as a key growth region. The global DNA diagnostics market is projected to grow from $13.2b in 2025 to ...

Introduction People with intellectual disability face significant barriers to accessing genetic healthcare, including during ...

Black kidney donors with the high-risk APOL1 genotype are about twice as likely to develop reduced kidney function as those without it. Medical algorithms consider all Black kidney donor candidates as ...